NALOXON OrPha sol inj 0.4 mg/ml 10 amp 1 ml

7680569520015 CH-56952 V03AB15 15.01.1.
NALOXON OrPha sol inj 0.4 mg/ml 10 amp 1 ml
NALOXON OrPha sol inj 0.4 mg/ml 10 amp 1 ml
NALOXON OrPha sol inj 0.4 mg/ml 10 amp 1 ml
1 / 3
google

Details

Product number
5695201
CPT
-
Packaging group
10
Unit
Ampulle(n)
Composition
naloxoni hydrochloridum anhydricum 0.4 mg ut naloxoni hydrochloridum dihydricum 0.44 mg, natrii chloridum, natrium 3.54 mg, acidum hydrochloridum, aqua ad iniectabile q.s. ad solutionem pro 1 ml.

Articles (1)

Naloxon OrPha, Injektionslösung
Injektionslösung
10
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Professional SmPC
Allemand
07/10/2021
Professional SmPC
Français
07/10/2021
Professional SmPC
Italien
07/10/2021

Detailed composition

Substance Quantity Type Category
(N/A)
0.4 MG Substance Wirkstoff (Principe actif)
(N/A)
0.44 MG Substance WIZUS
(N/A)
- Substance HNIDK
(N/A)
3.54 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK

Authorization holder

OrPha Swiss GmbH

8700 Küsnacht ZH

Authorization information

Swissmedic authorization number
56952
Drug name
Naloxon OrPha, Injektionslösung
Galenic form
LSPA
ATC Code
V03AB15
Authorization status
Z
Dispensation category
B
First authorization
07/06/2004
Authorization expiration date
31/12/9999
IT number
15.01.1.
Domain
Human medicine
Field of application
Opioid-Antagonist

Packaging details

Description (FR)
NALOXON OrPha sol inj 0.4 mg/ml 10 amp 1 ml
Description (DE)
NALOXON OrPha Inj Lös 0.4 mg/ml 10 Amp 1 ml
Market launch
07/06/2004
Narcotic (BTM)
No

Other packaging sizes